Combination of Metformin and Curcumin Targets Breast Cancer in Mice by Angiogenesis Inhibition, Immune System Modulation and Induction of P53 Independent Apoptosis

Overview

Journal Ther Adv Med Oncol

Specialty Oncology

Date 2017 May 12

PMID 28491145

Citations 34

Authors

Rabah Rashad Falah

Wamidh H Talib

Seba Jamal Shbailat

Affiliations

Soon will be listed here.

Abstract

Background: The effects of metformin (MET) and curcumin (CUR) single treatments have been tested against breast cancer; however, their combination has not been explored. Here, we evaluated the antitumor activity of MET and CUR combination against breast cancer in mice.

Materials And Methods: The antiproliferative activity of single and combined treatments against breast cancer cell lines was determined. Vascular endothelial growth factor (VEGF) and expression was examined in EMT6/P cells. studies were carried out by inoculating BALB/c mice with EMT6/P cells and examining tumor growth and apoptosis induction in tumor sections. Furthermore, serum levels of different cytokines and transaminases and creatinine were measured to detect the immune response and toxicity, respectively.

Results: The combination treatment exhibited the highest effects against tumor proliferation and growth. It significantly reduced VEGF expression, induced independent apoptosis, triggered Th2 immune response and showed no toxicity.

Conclusion: The combination can be a potential therapeutic option to treat breast cancer. However, further testing is needed to measure the exact serum levels of MET and CUR and to further explain the obtained results.

Citing Articles

Therapeutic Potential of Natural Compounds to Modulate WNT/β-Catenin Signaling in Cancer: Current State of Art and Challenges.

Gajos-Michniewicz A, Czyz M Int J Mol Sci. 2024; 25(23).

PMID: 39684513 PMC: 11641450. DOI: 10.3390/ijms252312804.

Molecular interactions between metformin and D-limonene inhibit proliferation and promote apoptosis in breast and liver cancer cells.

Salim E, Alabasy M, El Nashar E, Al-Zahrani N, Alzahrani M, Guo Z BMC Complement Med Ther. 2024; 24(1):185.

PMID: 38711049 PMC: 11071183. DOI: 10.1186/s12906-024-04453-x.

Curcumin reverses erastin-induced chondrocyte ferroptosis by upregulating Nrf2.

Zhou Y, Jia Z, Wang J, Huang S, Yang S, Xiao S Heliyon. 2023; 9(10):e20163.

PMID: 37771529 PMC: 10522940. DOI: 10.1016/j.heliyon.2023.e20163.

The promising therapeutic effects of metformin on metabolic reprogramming of cancer-associated fibroblasts in solid tumors.

Mostafavi S, Zalpoor H, Hassan Z Cell Mol Biol Lett. 2022; 27(1):58.

PMID: 35869449 PMC: 9308248. DOI: 10.1186/s11658-022-00356-2.

Curcumin and metformin synergistically modulate peripheral and central immune mechanisms of pain.

Dasuni Wasana P, Hasriadi , Muangnoi C, Vajragupta O, Rojsitthisak P, Rojsitthisak P Sci Rep. 2022; 12(1):9713.

PMID: 35690654 PMC: 9188603. DOI: 10.1038/s41598-022-13647-7.

References

Agrawal N, Bettegowda C, Cheong I, Geschwind J, Drake C, Hipkiss E . Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A. 2004; 101(42):15172-7. PMC: 523456. DOI: 10.1073/pnas.0406242101. View

Lu W, Qin Y, Yang C, Li L, Fu Z . Effect of curcumin on human colon cancer multidrug resistance in vitro and in vivo. Clinics (Sao Paulo). 2013; 68(5):694-701. PMC: 3654338. DOI: 10.6061/clinics/2013(05)18. View

Grossmann M, Yang D, Guo Z, Potter D, Cleary M . Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis. Curr Pharmacol Rep. 2015; 1(5):312-323. PMC: 4577062. DOI: 10.1007/s40495-015-0032-z. View

Topp M, Papadimitriou C, Eitelbach F, Koenigsmann M, Oelmann E, Koehler B . Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies. Cancer Res. 1995; 55(10):2173-6. View

Liu B, Fan Z, Edgerton S, Deng X, Alimova I, Lind S . Metformin induces unique biological and molecular responses in triple negative breast cancer cells. Cell Cycle. 2009; 8(13):2031-40. DOI: 10.4161/cc.8.13.8814. View

He H, Wang G, Gao Y, Ling W, Yu Z, Jin T . Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. World J Diabetes. 2012; 3(5):94-104. PMC: 3360224. DOI: 10.4239/wjd.v3.i5.94. View

Wang Y, Yu J, Cui R, Lin J, Ding X . Curcumin in Treating Breast Cancer: A Review. J Lab Autom. 2016; 21(6):723-731. DOI: 10.1177/2211068216655524. View

Koohpar Z, Entezari M, Movafagh A, Hashemi M . Anticancer Activity of Curcumin on Human Breast Adenocarcinoma: Role of Mcl-1 Gene. Iran J Cancer Prev. 2015; 8(3):e2331. PMC: 4581370. DOI: 10.17795/ijcp2331. View

Ichite N, Chougule M, Jackson T, Fulzele S, Safe S, Singh M . Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer. Clin Cancer Res. 2009; 15(2):543-52. PMC: 2866624. DOI: 10.1158/1078-0432.CCR-08-1558. View

10.

Chae Y, Arya A, Malecek M, Shin D, Carneiro B, Chandra S . Repurposing metformin for cancer treatment: current clinical studies. Oncotarget. 2016; 7(26):40767-40780. PMC: 5130043. DOI: 10.18632/oncotarget.8194. View

11.

Liu D, Chen Z . The effect of curcumin on breast cancer cells. J Breast Cancer. 2013; 16(2):133-7. PMC: 3706856. DOI: 10.4048/jbc.2013.16.2.133. View

12.

Talib W, AbuKhader M . Combinatorial Effects of Thymoquinone on the Anticancer Activity and Hepatotoxicity of the Prodrug CB 1954. Sci Pharm. 2013; 81(2):519-30. PMC: 3700079. DOI: 10.3797/scipharm.1211-15. View

13.

Phoenix K, Vumbaca F, Claffey K . Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat. 2008; 113(1):101-11. PMC: 2606917. DOI: 10.1007/s10549-008-9916-5. View

14.

Dallaglio K, Bruno A, Cantelmo A, Esposito A, Ruggiero L, Orecchioni S . Paradoxic effects of metformin on endothelial cells and angiogenesis. Carcinogenesis. 2014; 35(5):1055-66. PMC: 4004203. DOI: 10.1093/carcin/bgu001. View

15.

Tsvetkov P, Asher G, Reiss V, Shaul Y, Sachs L, Lotem J . Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci U S A. 2005; 102(15):5535-40. PMC: 556252. DOI: 10.1073/pnas.0501828102. View

16.

Shiri S, Alizadeh A, Baradaran B, Farhanghi B, Shanehbandi D, Khodayari S . Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1/m2 macrophage balance in the tumor microenvironment. Asian Pac J Cancer Prev. 2015; 16(9):3917-22. DOI: 10.7314/apjcp.2015.16.9.3917. View

17.

Barbieri F, Thellung S, Ratto A, Carra E, Marini V, Fucile C . In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors. BMC Cancer. 2015; 15:228. PMC: 4397725. DOI: 10.1186/s12885-015-1235-8. View

18.

Hegazy A, Peine M, Helmstetter C, Panse I, Frohlich A, Bergthaler A . Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity. 2010; 32(1):116-28. DOI: 10.1016/j.immuni.2009.12.004. View

19.

Poli G, Cantini G, Armignacco R, Fucci R, Santi R, Canu L . Metformin as a new anti-cancer drug in adrenocortical carcinoma. Oncotarget. 2016; 7(31):49636-49648. PMC: 5226535. DOI: 10.18632/oncotarget.10421. View

20.

Bostrom B, Uppal P, Chu J, Messinger Y, Gandrud L, McEvoy R . Safety and efficacy of metformin for therapy-induced hyperglycemia in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2013; 35(7):504-8. DOI: 10.1097/MPH.0b013e31829cdeba. View